Richard Voit

213 posts

Richard Voit

@RichardVoit

Pediatric hematology/oncology | Stem cell biology | AML | Gene therapy | CRISPR

UT Southwestern Katılım Aralık 2021

194 Takip Edilen325 Takipçiler

Sabitlenmiş Tweet

Richard Voit@RichardVoit·11 Kas

Gene therapy is transforming how we treat genetic disorders, but what if mutations in more than 30 genes can cause similar symptoms? Now published in @CellStemCell (cell.com/cell-stem-cell…), we report the development of a universal gene therapy for Diamond Blackfan anemia. 1/n

English

Richard Voit retweetledi

The V Foundation for Cancer Research@TheVFoundation·9 Oca

We fund researchers like @kennethschen, one of the brilliant minds that is helping to shape the future of cancer research. V Foundation researchers, throughout their careers, have generated $22 billion in additional cancer research funding. We truly fund the best of the best.

English

719

Richard Voit retweetledi

Blood Journals Portfolio@BloodPortfolio·25 Ara

MECOM promotes malignant stem cell–like states in aggressive AMLs by directly repressing prodifferentiation gene regulatory programs. Read the plenary paper in Blood: ow.ly/Nrko50XNqJk #BloodJournal #PlenaryPaper #AML

English

3.3K

Richard Voit@RichardVoit·19 Ara

Proud of you @tjflemin for your incredibly hard work on this. Now the next frontier: inhibiting this pathway in a clinically tractable way.

Vijay Sankaran@bloodgenes

Terrific to have our paper, led by @tjflemin, featured as a plenary article in @BloodPortfolio today: ashpublications.org/blood/article/…

English

560

Richard Voit@RichardVoit·15 Eki

Congratulations @Mendell_lab. What an interesting mechanism!

Joshua Mendell@Mendell_lab

Colliding ribosomes are potent signals of cellular stress. But do cells use ‘programmed’ ribosome collisions to regulate gene expression? I’m excited to present a new story led by Frederick Rehfeld revealing that the answer is YES! Read on to find out how. biorxiv.org/content/10.110…

English

481

Richard Voit retweetledi

Children’s Research Institute at UT Southwestern@CRI_UTSW·12 Ağu

Congrats! 👏👏👏 Two CRI scientists named 2025 Pew-Stewart & Pew Scholars — @JaviGBermudez & @HijaiShin — to advance cancer, biomedical research. Read more about their #relentlessdiscovery ⬇️ cri.utsw.edu/two-childrens-… @pewtrusts

English

10.6K

Richard Voit@RichardVoit·2 Ağu

Looking forward to the #NFRF2025 @UTSWScience in October. utsouthwestern.edu/education/prov…. If you are an undifferentiated trainee @UTSWMedCenter, come check out highlights from new labs on campus.

UTSW Science@UTSWScience

Committed to advancing treatments for children with blood disorders, @RichardVoit is exploring the complexities of hematopoietic stem cells to enhance targeted leukemia therapies. Discover more: voitlab.org #NFRF2025 #NFRF

English

673

Richard Voit retweetledi

Dr. Arnaldo Díaz@ADiaz_PhD·8 Tem

Inspiring piece in ⁦⁦@NatureCancer⁩, "An unexpected career in cancer metabolism," highlights Dr. Ralph DeBerardinis & the pivotal moments that prompted him to pursue a career in cancer metabolism. ⁦⁦@CRI_UTSW⁩ ⁦⁦@HHMINEWS⁩ nature.com/articles/s4301…

English

4.8K

Richard Voit retweetledi

Elizabeth McKenna@ElizSMcKenna·23 Haz

Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia - by @ShellainaGordon @florian_perner, @Armstrong_dfci, @MAF_Dawson @TheDawsonLab et al. doi.org/10.1158/2159-8… @PeterMacRes @DanaFarber

English

5.7K

Richard Voit retweetledi

Elizabeth McKenna@ElizSMcKenna·23 Haz

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia @NMichmerhuizen, Emily Heikamp, @Armstrong_dfci, @CMullighan and colleagues doi.org/10.1158/2159-8… @StJudeResearch @DanaFarber

English

991

Richard Voit retweetledi

Elvin Wagenblast@Elvin_Wag·22 Haz

Be part of the Wagenblast Lab! We are hiring a Lab Manager for leukemia & blood stem cell research at @IcahnMountSinai in NYC, starting July 2025. See ad to apply!

English

2.8K

Richard Voit@RichardVoit·4 Haz

Congratulations @michaelpoeschla and @bloodgenes. Incredible work!

Vijay Sankaran@bloodgenes

Delighted to have our work on Polygenic Modifiers of #TelomereBiologyDisorders, led by @michaelpoeschla, along with @SashaGusevPosts, @mitchiela, @SharonSavageMD, @hemanth_tummala, and others, published as an advanced online paper in @jclinicalinvest today: jci.org/articles/view/…

English

346

Richard Voit retweetledi

Iannis Aifantis@iannisaifantis1·22 May

Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during their treatment! Out today @CellStemCell !! An amazing collaboration with @AkEisfeld & @PapaemmanuilLab & @landau_lab !!! Driven by the impressive @MariaSirenko and @soobeomlee & Zhengxi Sun at @NYUGSOM_Path

English

244

34.3K

Richard Voit@RichardVoit·14 May

Kids like KK motivate everything we do in the lab @utswcancer @CRI_UTSW @UTSW_PedsHemOnc. We are now hiring so if you are looking for the next step in your scientific journey or want to learn more about what we do, please reach out.

English

631

Richard Voit@RichardVoit·14 May

We at voitlab.org are grateful to @TexasCCF for supporting our work. Thank you also to @dallascowboys @dak, @Jalen8Tolbert, @tonyromo, @TroyAikman for using their platform to raise awareness and funds for pediatric cancer research. youtu.be/KZwX8Mf7n5I

YouTube

English

996

Richard Voit@RichardVoit·8 Nis

Congratulations Elvin and team. This is a really elegant way to probe an important clinical question underlying aggressive AMLs.

Elvin Wagenblast@Elvin_Wag

Thrilled to share the first pre-print from our lab! We tackled a big question: Why are some pediatric leukemias extremely aggressive? We explored the developmental origins of fusion-driven acute myeloid leukemia (AML). Let's dive in! #AML #NUP98 n/13

English

531

Richard Voit retweetledi

Vijay Sankaran@bloodgenes·4 Nis

Delighted to have our Perturb-multiome paper, led by @jmartinrufino and #AlexisCaulier from our lab, published today in @ScienceMagazine. Please check out this powerful approach to decipher gene regulatory networks enriched for genetic variation: science.org/doi/10.1126/sc…

English

359

33.2K

Richard Voit retweetledi

Dana-Farber News@DanaFarberNews·6 Mar

Congratulations to @DanaFarber’s Lara Wahlster, MD, PhD, and Nina Weichert-Leahey, MD, for receiving the American Society for Clinical Investigation Emerging-Generation Awards. Read about Dr. Wahlster at bit.ly/4haxdTW and Dr. Weichert-Leahey at bit.ly/4h6BYxL.

English

2.3K

Richard Voit retweetledi

Vijay Sankaran@bloodgenes·6 Mar

Incredibly proud of @tGaoTeng from our lab, who is a recipient of the @HHMINEWS-@DamonRunyon fellowship!!! Congratulations, Teng!! damonrunyon.org/news/entries/8…

English

9.1K

Richard Voit retweetledi

Caleb Lareau@CalebLareau·19 Şub

I am so excited to be selected as one of the recipients of the Michelson Prize from the Michelson Medical Research Foundation and the @ImmunomePro! This award enables our lab's research at the intersection of systems immunology, virology, and large-scale genomics research.

Human Immunome Project@ImmunomePro

Congratulations to Dr. Caleb Lareau, 2024 #MichelsonPrizes recipient! His work will study the blood virome and answer the critical question: how do humans have vastly different responses to the same infection?

English

107

Richard Voit retweetledi

Dana-Farber News@DanaFarberNews·14 Şub

Congratulations @LWahlster of @DanaFarber who has been named a 2025 Damon Runyon-St. Jude Pediatric Cancer Research Fellow. Read more: bit.ly/42T5TWQ

English

1.9K

Keşfet

@kennethschen @tjflemin @Mendell_lab @JaviGBermudez @HijaiShin @pewtrusts @UTSWScience @UTSWMedCenter